Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Net Income towards Common Stockholders (2021 - 2025)

Tenon Medical has reported Net Income towards Common Stockholders over the past 5 years, most recently at -$2.9 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 9.68% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached -$12.8 million, up 7.3%, while the annual FY2025 figure was -$12.8 million, 7.3% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$2.9 million at Tenon Medical, up from -$3.4 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$200000.0 in Q1 2021 and troughed at -$7.9 million in Q4 2022.
  • A 5-year average of -$3.4 million and a median of -$3.2 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 1076.5% in 2022 and later surged 60.13% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$2.8 million in 2021, then crashed by 178.58% to -$7.9 million in 2022, then surged by 60.13% to -$3.2 million in 2023, then fell by 0.47% to -$3.2 million in 2024, then rose by 9.68% to -$2.9 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for TNON at -$2.9 million in Q4 2025, -$3.4 million in Q3 2025, and -$2.9 million in Q2 2025.